
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Advaxia Biologics (formerly Advent), part of the IRBM group, is a cGMP Contract Development & Manufacturing Organisation (CDMO), located near Rome (Pomezia) Italy, compliant with the regulatory guidelines of the EMA, MHRA and FDA. Advaxias integrated contract services portfolio includes outstanding support in the areas of analytical method development, process development/validation, in-process assay development & qualification, GMP Manufacture, full QC product release, ICH Stability and cell banking. Advaxia is dedicated to the development and production of clinical lots of recombinant adenoviruses to support clinical trials for vaccine and gene therapy applications. The Advaxia team has built an outstanding track record...
Adenovirus,process development,cgmp manufacture,viral vectors,vaccines,analytical development,quality control,stability,cell line development,and cell-based assays
Advaxia biologics operates in the Pharmaceutical manufacturing industry.
Advaxia biologics's revenue is 11m - 100m
Advaxia biologics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.